Borosil Scientific Q3 PAT Surges 103%, But 9-Month Profit Plunges 59% on One-offs

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorAkshat Lakshkar|Published at:
Borosil Scientific Q3 PAT Surges 103%, But 9-Month Profit Plunges 59% on One-offs
Overview

Borosil Scientific posted a strong Q3 FY26 with consolidated PAT soaring 103.18% YoY to ₹869.75 lakhs, driven by robust revenue growth. However, the nine-month period paints a different picture, with consolidated PAT declining 59.50% to ₹733.53 lakhs, heavily impacted by exceptional expenses including a ₹661.31 lakh Voluntary Retirement Scheme (VRS) settlement and ₹191.51 lakh impact from new Labour Codes. Standalone results mirror this trend, with Q3 PAT up 52.76% but 9-month PAT down 12.73%. No management guidance was provided.

📉 The Financial Deep Dive

Borosil Scientific Limited's Q3 FY26 results present a tale of two halves: a strong quarterly rebound overshadowed by significant year-to-date profitability erosion due to exceptional items. On a consolidated basis, the company reported a robust 19.47% year-on-year (YoY) revenue growth in Q3 FY26, reaching ₹12,120.76 lakhs. This top-line expansion translated into a remarkable 103.18% surge in consolidated Profit After Tax (PAT), which climbed to ₹869.75 lakhs from ₹428.02 lakhs in the prior year's quarter. Consequently, basic Earnings Per Share (EPS) doubled from ₹0.48 to ₹0.98.

However, a deeper dive into the nine-month period (9M FY26) reveals considerable pressure on profitability. Consolidated revenue grew a modest 4.91% YoY to ₹32,417.28 lakhs. Yet, consolidated PAT plummeted by a staggering 59.50% YoY to ₹733.53 lakhs. This steep decline is primarily attributable to significant exceptional expenses aggregating ₹852.82 lakhs for the nine-month period. These included a substantial ₹661.31 lakh payout for a Voluntary Retirement Scheme (VRS) and an additional ₹191.51 lakh impact arising from the implementation of new Labour Codes. The standalone results echo this divergence, with Q3 FY26 standalone PAT rising 52.76% YoY to ₹1,021.07 lakhs on a 14.39% revenue increase, while 9M FY26 standalone PAT fell 12.73% YoY to ₹1,818.89 lakhs, also impacted by these one-off costs.

The Numbers:

  • Consolidated Q3 FY26: Revenue ₹12,120.76 lakhs (+19.47% YoY), PAT ₹869.75 lakhs (+103.18% YoY), EPS ₹0.98 (+104.17% YoY).
  • Standalone Q3 FY26: Revenue ₹10,712.04 lakhs (+14.39% YoY), PAT ₹1,021.07 lakhs (+52.76% YoY), EPS ₹1.15 (+53.33% YoY).
  • Consolidated 9M FY26: Revenue ₹32,417.28 lakhs (+4.91% YoY), PAT ₹733.53 lakhs (-59.50% YoY), EPS ₹0.83 (-59.31% YoY).
  • Standalone 9M FY26: Revenue ₹29,561.13 lakhs (+7.58% YoY), PAT ₹1,818.89 lakhs (-12.73% YoY), EPS ₹2.04 (-12.77% YoY).

Segment Performance:
The company's operational segments are 'Scientific — Laboratory Glass & equipment and Process System' and 'Glassware'. While the Scientific segment showed growth in Q3 FY26, the Glassware segment reported lower profits before tax on a standalone basis for the quarter compared to the previous year. This indicates potential pressure points within specific business verticals.

The Grill:
No analyst call transcript was provided, and the results announcement itself did not contain any challenging management commentary or aggressive analyst questioning. The results are presented as factual financial data.

Red Flags:
The primary red flag is the significant deterioration in nine-month PAT, especially on a consolidated basis, driven entirely by substantial exceptional expenses. The VRS payout, a one-time cost, will not recur, but the impact of new Labour Codes may persist. Furthermore, the lack of forward-looking guidance from management introduces uncertainty regarding future performance and profitability trends. The declining profitability in the Glassware segment also warrants attention.

🚩 Risks & Outlook

Specific Risks:

  1. Sustainability of Q3 Growth: The strong Q3 PAT growth needs to be assessed independent of the exceptional items that inflated it. Without these one-offs, the underlying operational profitability trend is crucial.
  2. Impact of New Labour Codes: The recurring impact of the ₹191.51 lakh expense due to new Labour Codes needs to be factored into future cost structures.
  3. Segmental Performance: Weakness in the Glassware segment's profitability could hinder overall growth if not addressed.
  4. Lack of Guidance: The absence of management commentary on future outlook, demand drivers, or margin expectations makes it difficult for investors to gauge the company's trajectory.

The Forward View:
Investors will be keenly watching the commentary in subsequent earnings calls and reports to understand the operational performance of Borosil Scientific, especially as the impact of the VRS settlement recedes. The ability of the company to sustain Q3-like profitability without relying on exceptional items, and to improve the performance of its Glassware segment, will be key indicators. The market will also look for any signs of future guidance or strategic initiatives to counter market headwinds and ensure sustained growth.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.